NCT04793178 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Merry AF, Cooper JB, Soyannwo O, Wilson IH, Eichhorn JH
International Standards for a Safe Practice of Anesthesia 2010. Can J Anaesth. 2010 Nov;57(11):1027-34. doi: 10.1007/s12630-010-9381-6. Epub 2010 Sep 21.
Sacchetti A, Senula G, Strickland J, Dubin R
Procedural sedation in the community emergency department: initial results of the ProSCED registry. Acad Emerg Med. 2007 Jan;14(1):41-6. Epub 2006 Aug 31.

The Effectivity of End-tidal CO2 and Oxygen Reserve Index (ORI) Monitoring to Detect Respiratory Events and Hypoxemia Before Pulse Oxymetry in Sedation

Details for clinical trial NCT04793178

Clinical trial NCT04793178 - References